• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Shire

edit

Shire PLC is a specialty biopharmaceutical company. They have a global sales and marketing infrastructure with a broad portfolio of products and direct marketing capability in the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain.

Milestones

edit

• 
  Shire invested in Promethera Biosciences. (3/28/12)
  Posted 3/28/12 at 6:16pm via finsmes.com
• 
  Shire invested in Prexa Pharmaceuticals. (5/11/11)
  Posted 5/11/11 at 7:13pm via prexainc.com
• 
  Shire invested in NeuroPhage Pharmaceuticals. (3/1/11)
  Posted 3/1/11 at 8:10pm via neurophage.com
• 
  Shire acquired Advanced BioHealing. (5/17/11)
  Posted 5/20/11 at 4:37am via yahoo.com
• 
  Shire acquired Movetis for $565M. (8/3/10)
  Posted 8/6/10 at 11:19am via fiercebiotech.com
• 
  Shire — Shire plc has named Philip J. Vickers as senior vice president of research and development for the company’s Human Genetic Therapies division (10/11/10)
  Posted 10/12/10 at 4:54am via masshightech.com
• 
  Shire — Shire HGT appoints Philip Vickers as SVP of R&D (10/11/10)
  Posted 10/11/10 at 10:20am via masshightech.com
• 
  Shire — Shire launches Facebook page for Gaucher disease month (9/3/10)
  Posted 9/7/10 at 4:16am via masshightech.com

Videos

Screenshots

edit

Sources

1. Shire to buy Advanced BioHealing for $750 million (finance.yahoo.com) [edit]
2. Shire forges $565M buyout deal for Movetis (fiercebiotech.com) [edit]
3. Promethera Biosciences Raises €23.6M in Series B Funding (finsmes.com) [edit]
4. Prexa Pharmaceuticals Obtains $7.0 million in Series B Financing (prexainc.com) [edit]
5. NeuroPhage Pharmaceuticals closes $12.4M Series B round (neurophage.com) [edit]
Shire launches Facebook page for Gaucher disease month (masshightech.com) [edit]
Mass High Tech (masshightech.com) [edit]
Shire HGT appoints Vickers as senior VP of R&D (masshightech.com) [edit]